GlassScriptPhysician profile
Timothy J Oldani
NPI 1225143480
$17,945.66
in general payments reported to CMS, 2019-2025
22 companies · $89.84 in 2025
The $89.84 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $65.20 · 2021: $1,659 · 2022: $6,198 · 2023: $8,171 · 2024: $1,449 · 2025: $89.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,650 · Travel and Lodging: $1,165 · Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,650.00 |
| Travel and Lodging | $1,165.46 |
| Food and Beverage | $894.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $9,115.31 | 2023-2024 | |
| Triad Life Sciences INC. | $7,447.88 | 2021-2022 | |
| Stryker Corporation | $379.60 | 2022-2024 | Ortholoc 3di Crosscheck, Actishield, Viaflow |
| Smith+Nephew, INC. | $230.21 | 2019-2023 | Collagenase Santyl, Regranex |
| Angiodynamics, INC. | $118.18 | 2021 | |
| Organogenesis INC. | $96.54 | 2023-2024 | Affinity, Puraply |
| Reprise Biomedical, INC. | $89.84 | 2025 | Miro3d |
| Melinta Therapeutics, LLC | $75.12 | 2019 | |
| Integra Lifesciences Corporation | $63.16 | 2019-2020 | |
| Ets Wound Care LLC | $57.91 | 2024 | Mirragen Advanced Wound Matrix |
| Medtronic, INC. | $56.75 | 2022-2023 | Vanta Adaptivestim |
| Paragon 28, INC. | $41.66 | 2022 | |
| Tei Medical INC. | $28.61 | 2019 | |
| Elite Orthopedics, LLC | $24.19 | 2020-2021 | |
| Kci USA, INC. | $17.87 | 2023 | V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.39 | 2019 | |
| Acera Surgical, INC. | $15.57 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.84 | 2021 | |
| Sandoz INC. | $14.74 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.58 | 2023 | Jublia |
| Pierre Fabre Pharmaceuticals, INC. | $13.79 | 2019 | |
| Hartmann USA, INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Oldani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.